ZETONNA (R) is a new non-aqueous, dry nose spray for allergic rhinitis: http://www.zetonna.com. It contains ciclesonide just like OMNARIS (hypotonic).
Zetonna is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.
It is the only dry nasal aerosol approved by the FDA with once daily, one spray per nostril (37 mcg) dosing. The other dry spray intranasal steroid (INS) is Qnasl (Beclomethasone Nasal Inhalation, http://www.qnasl.com), and it is approved for use as 2 sprays per nostril.
Zetonna is the only dry nasal aerosol that is FDA approved for the treatment of ocular (eye) symptoms associated with SAR (that does not mean that Qnasl does not work for those too).
In clinical trials, the most common adverse events reported were nasal discomfort, headache and nosebleed.
Treatment Options for Allergic Rhinitis and Non-Allergic Rhinitis (click to enlarge the image).
Sunovion Pharmaceuticals Inc. Announces Nationwide Availability of ZETONNA(TM) (ciclesonide) Nasal Aerosol for Allergic Rhinitis - MarketWatch http://goo.gl/oNXI9
Images source: Wikipedia, a free GNU license and public domain.
Comments from Twitter:
Paul @WebTrawler: Unfortunately dry INS are not yet available in AU. Have come across Drs prescribing budesonide turbuhaler for nasal use. Not ideal!